Arcus Biosciences, Inc.RCUSNYSE
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+22.0%
5Y CAGR+26.9%
Year-over-Year Change
Research and development spending
3Y CAGR
+22.0%/yr
vs +55.2%/yr prior
5Y CAGR
+26.9%/yr
Recent deceleration
Acceleration
-33.2pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.3x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $523.00M | +16.7% |
| 2024 | $448.00M | +31.8% |
| 2023 | $340.00M | +18.1% |
| 2022 | $288.00M | +12.1% |
| 2021 | $257.00M | +61.6% |
| 2020 | $159.00M | +102.6% |
| 2019 | $78.48M | +58.1% |
| 2018 | $49.65M | +5.1% |
| 2017 | $47.22M | +231.4% |
| 2016 | $14.25M | - |